Our observations extend recent in vitro and animal reports on anti-allergic effects of AZD8848, indicating that repeated TLR7 stimulation reduces the responsiveness to allergen [19-23], and suggest that AZD8848 may be clinically effective in allergic rhinitis. This evidence concerns the gene TLR7 and allergic rhinitis.